IYH CL Stock Overview
iShares Trust - iShares U.S. Healthcare ETF is an exchange traded fund launched by BlackRock, Inc.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
iShares Trust - iShares U.S. Healthcare ETF Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$56,252.00 |
| 52 Week High | US$61,366.00 |
| 52 Week Low | US$42,856.00 |
| Beta | 0.69 |
| 1 Month Change | -0.90% |
| 3 Month Change | -1.52% |
| 1 Year Change | 11.11% |
| 3 Year Change | 49.42% |
| 5 Year Change | n/a |
| Change since IPO | 58.72% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| IYH CL | CL Capital Markets | CL Market | |
|---|---|---|---|
| 7D | 1.2% | 1.7% | 2.4% |
| 1Y | 11.1% | 8.3% | 17.5% |
Return vs Industry: IYH CL exceeded the CL Capital Markets industry which returned 8.8% over the past year.
Return vs Market: IYH CL underperformed the CL Market which returned 17% over the past year.
Price Volatility
| IYH CL volatility | |
|---|---|
| IYH CL Average Weekly Movement | 1.5% |
| Capital Markets Industry Average Movement | 3.0% |
| Market Average Movement | 3.1% |
| 10% most volatile stocks in CL Market | 4.9% |
| 10% least volatile stocks in CL Market | 1.2% |
Stable Share Price: IYH CL has not had significant price volatility in the past 3 months.
Volatility Over Time: IYH CL's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | n/a | www.ishares.com/us/products/239511/ishares-us-healthcare-etf |
iShares Trust - iShares U.S. Healthcare ETF is an exchange traded fund launched by BlackRock, Inc. The fund is managed by BlackRock Fund Advisors. The fund invests in public equity markets of the United States.
iShares Trust - iShares U.S. Healthcare ETF Fundamentals Summary
| IYH CL fundamental statistics | |
|---|---|
| Market cap | CL$3.10t |
| Earnings (TTM) | -CL$132.03b |
| Revenue (TTM) | CL$47.99b |
64.6x
P/S Ratio-23.5x
P/E RatioIs IYH CL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IYH CL income statement (TTM) | |
|---|---|
| Revenue | US$51.78m |
| Cost of Revenue | US$0 |
| Gross Profit | US$51.78m |
| Other Expenses | US$194.24m |
| Earnings | -US$142.46m |
Last Reported Earnings
Oct 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.57 |
| Gross Margin | 100.00% |
| Net Profit Margin | -275.13% |
| Debt/Equity Ratio | 1.8% |
How did IYH CL perform over the long term?
See historical performance and comparison